| Income Statement for Sciele Pharma Inc. (SCRX) | | | | | | | Income | in Thousands of Dollars | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Operating Revenue | 382,255 | 293,181 | 216,358 | 151,967 | 95,305 | | Adjustments to Revenue | - | - | - | - | - | | Cost of Revenue | (52,755) | (40,687) | (33,331) | (29,082) | (17,734) | | Gross Operating Profit | 329,500 | 252,494 | 183,027 | 122,885 | 77,571 | | | Selling/General/Admin Expense | (190,758) | (145,254) | (97,386) | (66,773) | (57,822) | | Research & Development | (32,722) | (16,587) | (4,075) | (1,546) | (2,085) | | EBITDA | 106,020 | 90,653 | 81,566 | 54,566 | 17,664 | | Depreciation & Amortization | (28,432) | (25,942) | (22,666) | (16,907) | (16,489) | | EBIT | 77,588 | 64,711 | 58,900 | 37,659 | 1,175 | | Interest Income | 9,401 | 4,943 | 3,209 | 3,802 | 393 | | Other Income, Net | (5,256) | (43) | (710) | (12) | (3) | | Total Income Avail For Interest Expense | 76,833 | 69,611 | 61,399 | 41,449 | (2,587) | | Interest Expense | (8,654) | (3,230) | (3,013) | (2,480) | (194) | | Pre-Tax Income | 68,179 | 66,381 | 58,386 | 38,969 | (2,781) | | Income Taxes | (22,772) | (21,137) | (19,177) | (12,415) | 1,043 | | Minority Interest | - | - | - | - | - | | Net Income from Continuing Operations | 45,407 | 45,244 | 39,209 | 26,554 | (1,738) | | Net Income from Discontinued Operations | - | - | - | - | - | | Net Income from Total Operations | 45,407 | 45,244 | 39,209 | 26,554 | (1,738) | | | Normalized Income | 50,307 | 45,244 | 39,209 | 26,554 | 2,414 | | Extraordinary Income | - | - | - | - | - | | Special Income/Charges | (4,900) | - | - | - | (4,152) | | Income from Cum. Effect of Acct Change | - | - | - | - | - | | Income from Tax Loss Carryforward | - | - | - | - | - | | Other Gains | - | - | - | (401) | 264 | | Total Net Income | 45,407 | 45,244 | 39,209 | 26,153 | (1,474) | | | Results | in Dollars (Preferred Dividends in Thousands) | | | 12/2007 | 12/2006 | 12/2005 | 12/2004 | 12/2003 | | | Dividends Paid Per Share | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Preferred Dividends | - | - | - | - | - | | | Basic EPS from Continuing Operations | 1.28 | 1.29 | 1.12 | 0.74 | -0.05 | | Basic EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Basic EPS from Total Operations | 1.28 | 1.29 | 1.12 | 0.74 | -0.05 | | | Diluted EPS from Continuing Operations | 1.25 | 1.20 | 0.97 | 0.66 | -0.05 | | Diluted EPS from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | | Diluted EPS from Total Operations | 1.25 | 1.20 | 0.97 | 0.66 | -0.05 | | | |
